Alembic Pharma gets five perceptions from USFDA for Gujarat office Kumar Jeetendra | February 8, 2021 Alembic Pharmaceuticals on Monday said the US health regulator has made five observations after inspection at its center at Karkhadi, Gujarat. “The United States Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals” New Injectable Facility (F-3) located at Karkhadi from January 29-February 5, 2021. This was a scheduled inspection and at …
Revelation may decrease the ecological effect of chemical manufacturing Kumar Jeetendra | February 7, 2021 Chemical manufacturers frequently use toxic solvents such as alcohols and benzene to make products such as pharmaceuticals and plastics. Researchers are analyzing a previously overlooked and misunderstood phenomenon in the chemical reactions used to make these products. Combining metal and ore nanoparticles hastens many chemical reactions and helps maximize yield and profit margins for the …
Oxford/AstraZeneca COVID shot less viable against South African variant: Study Kumar Jeetendra | February 7, 2021 British drugmaker AstraZeneca said on Saturday its vaccine developed by the University of Oxford seemed to offer only limited protection against mild disease caused by the South African version of COVID-19, based on early data from a trial. The study from South Africa’s University of the Witwatersrand and Oxford University revealed the vaccine had significantly …
Business certainty improves with rollout of vaccines: NCAER Kumar Jeetendra | February 7, 2021 The Business Confidence Index (BCI) developed by the Delhi-based economic think tank NCAER rose 29.6 per cent between third and second quarter of the current financial year on the back of rollout of COVID-19 vaccines in various countries, such as India. The proportion of respondents anticipating that”overall economic conditions will improve in the next six …
Oxford says COVID-19 immunization with AstraZeneca neutralizes UK variant Kumar Jeetendra | February 6, 2021 AstraZeneca and Oxford University’s COVID-19 vaccine has similar efficacy against the British coronavirus version as it does to the previously circulating variants, the university said on Friday. The version, first identified in Kent, southern England, is more readily transmissible, prompting many countries to limit travel to Britain. It also led to a spike in infections …
Johnson and Johnson files COVID-19 immunization application with US FDA Kumar Jeetendra | February 5, 2021 Johnson & Johnson said it has asked US health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it’ll apply to European authorities in coming weeks. The drugmaker’s application to the U.S. Food and Drug Administration (FDA) follows its Jan. 29 report where it said the vaccine had a 66% rate of preventing …
Serum Institute of India postpones antibodies for private sale in Bangladesh; center around state campaigns Kumar Jeetendra | February 4, 2021 Bangladesh’s Beximco Pharmaceuticals Ltd said on Thursday the Serum Institute of India (SII) had delayed the first supplies of a COVID-19 vaccine for personal sale, instead prioritising government immunisation campaigns. Beximco is Bangladesh’s exclusive distributor of the Oxford University-AstraZeneca shot that SII, the world’s biggest vaccine maker, is producing in bulk for low- and medium-income …
Glenmark Pharma gets USFDA gesture for seizure treatment drug Kumar Jeetendra | February 4, 2021 Drug major Glenmark Pharma on Wednesday said it has received final approval from the US health regulator for Topiramate extended-release capsules, used to treat certain types of seizures. The approved product is a generic version of Qudexy XR Capsules of Upsher-Smith Laboratories, LLC. Glenmark Pharmaceuticals Ltd has received final approval from the United States Food …
Pfizer sees about $15 billion of every 2021 sales from COVID-19 immunization Kumar Jeetendra | February 2, 2021 Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German spouse BioNTech and raised its full-year profit forecast. The company said it expects total 2021 earnings of between $59.4 billion and $61.4 billion. The vaccine was among the first to be authorized for emergency …
CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021 Kumar Jeetendra | February 1, 2021 The recently hosted CPhI & P-MEC China 2020 – organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. – attracted a remarkable 46,157 visits of professional pharma visitors, including 5,105 international attendees taking part online. The hybrid event has helped stimulate renewed growth and partnerships across the …
AstraZeneca to supply 9 million more antibody dose to European Union Kumar Jeetendra | February 1, 2021 Pharmaceutical company AstraZeneca has agreed to provide 9 million additional doses of its coronavirus vaccine into the European Union during the first quarter, the bloc’s executive arm said Sunday. The new target of 40 million doses by the end of March is still only half what the British-Swedish firm had originally aimed for before it …
Johnson and Johnson 1-dose shot forestalls COVID-19, however not exactly some others Kumar Jeetendra | January 29, 2021 Johnson & Johnson’s long-awaited vaccine seems to protect against COVID-19 with just 1 shot — not as strong as some two-shot rivals but still potentially helpful for a world in dire need of more doses. J&J said Friday that in the U.S. and seven other nations, the single-shot vaccine was 66% effective overall at preventing …
